[Federal Register Volume 67, Number 30 (Wednesday, February 13, 2002)]
[Notices]
[Page 6728]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-3429]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Director, National Institutes of Health; Notice of 
Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of 
the Recombinant DNA Advisory Committee.
    The meeting will be open to the public, with attendance limited to 
space available. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should notify the Contact Person listed below in 
advance of the meeting.

    Name of Committee: Recombinant DNA Advisory Committee.
    Date: March 7-8, 2002.
    Time: 8 a.m. to 5 p.m.
    Agenda: RAC will review and discuss: selected human gene 
transfer protocols; data management activities related to human gene 
transfer clinical trials; informed consent issues; Liver-Directed 
Gene Transfer of rAAV for Hemophilia B; Update of Clinical Protocol 
and Data. The RAC meeting will be Web cast and can be viewed at 
http://www.webconferences.com/nihoba during the meeting.
    Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD 
20814.
    Contact Person: Laurie Harris, RAC Program Assistant, Office of 
Biotechnology Activities, Rockledge 1, Room 750, Bethesda, MD 20892, 
301-496-9839.
    Information is also available on the Institute's/Center's home 
page: www4.od.nih.gov/oba/, where an agenda and any additional 
Information for the meeting will be posted when available.


OMB's ``Mandatory Information Requirements for Federal Assistance 
Program Announcements'' (45 FR 39592, June 11, 1980) requires a 
statement concerning the official government programs contained in 
the Catalog of Federal Domestic Assistance. Normally NIH lists in 
its announcements the number and title of affected individual 
programs for the guidance of the public. Because the guidance in 
this notice covers virtually every NIH and Federal research program 
in which DNA recombinant molecule techniques could be used, it has 
been determined not to be cost effective or in the public interest 
to attempt to list these programs. Such a list would likely require 
several additional pages. In addition, NIH could not be certain that 
every Federal program would be included as many Federal agencies, as 
well as private organizations, both national and international, have 
elected to follow the NIH Guidelines. In lieu of the individual 
program listing, NIH invites readers to direct questions tot he 
information address above about whether individual programs listed 
in the Catalog of Federal Domestic Assistance are affected.

(Catalogue of Federal Domestic Assistance Program Nos. 93.14, 
Intramural Research Training Award; 93.187, Undergraduate 
Scholarship Program for Individuals from Disadvantaged Backgrounds; 
93.22, Clinical Research Loan Repayment Program for Individuals from 
Disadvantaged Backgrounds; 93.232, Loan Repayment Program for 
Research Generally; 93.39, Academic Research Enhancement Award; 
93.936, NIH Acquired Immunodeficiency Syndrome Research Loan 
Repayment Program, National Institutes of Health, HHS)

    Dated: February 5, 2002.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 02-3429 Filed 2-12-02; 8:45 am]
BILLING CODE 4140-01-M